OSRX expands medication sizes and adds direct-to-patient post-op kits

(Image Credit: AdobeStock/Iuliia Alekseeva)

OSRX is introducing new medications and direct-to-patient post-op kits, which are designed to streamline workflows for eye care professionals and enhance patient experience.

Among the offerings, OSRX can provide Tropicamide 1% + Phenylephrine 2.5%* in a 10mL fill, in addition to 2mL. The company notes that this larger size may provide a better value, helping practices to cut down on reorders, streamline processes, and reduce medical waste while ensuring quality care for patients.¹

Paul Mann, MD, Mann Eye Institute, is quoted in the company’s press release¹ on this news, saying, "When I started prescribing OSRX’s Tropicamide/Phenylephrine HCl dilation drops over two years ago, our patient process completely transformed. The medications provide our patients with what they need, and as an added benefit, using OSRX has streamlined our procedures, enabling us to focus even more on what we do best: providing exceptional patient care."

The company is also offering an expanded 5mL option of Brimonidine 0.1% + Dorzolamide 2%, which may deliver greater convenience for prescribers while keeping costs in check for patients. The company notes that this option is optimized for combination therapy management and available for direct-to-patient shipping or office stock.¹

OSRX has also partnered with a third-party manufacturer to offer exclusive direct-to-patient post-op kits, reducing logistical burdens on practices. Each kit includes a durable post-op bag, Solar Shield sunglasses, and a polycarbonate eye shield and tape.¹

Reference:

1. OSRX Expands Ophthalmic Solutions with New Medications and Post-Op Kits to Patients’ Doors. OSRX. March 17, 2025. Accessed March 18, 2025. https://www.businesswire.com/news/home/20250317365273/en/OSRX-Expands-Ophthalmic-Solutions-with-New-Medications-and-Post-Op-Kits-to-Patients-Doors